Revenue: The sum of all revenue fields included for a company's operating activities.
CNS Pharmaceuticals, Inc. (CNSP) Revenue data is not available.
Income Statement Financials | |
Revenue |
-- |
$-14.86M |
|
-- |
|
-- |
|
$14.90M |
|
$-14.90M |
|
$0.04M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.90M |
|
$-14.90M |
|
0.03M |
|
0.03M |
|
$-466.63 |
|
$-466.63 |
|
Balance Sheet Financials | |
$8.66M |
|
$0.01M |
|
$0.04M |
|
$8.70M |
|
$2.52M |
|
-- |
|
-- |
|
$2.52M |
|
$6.18M |
|
$6.18M |
|
$6.18M |
|
0.12M |
|
Cash Flow Statement Financials | |
$-17.11M |
|
$-0.00M |
|
$23.03M |
|
$0.55M |
|
$6.46M |
|
$5.91M |
|
$1.44M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.43 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-240.55% |
|
-240.55% |
|
-170.76% |
|
-240.55% |
|
$52.44 |
|
$-537.94 |
|
$-537.81 |